{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T20:13:14Z","timestamp":1649016794326},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:00:00Z","timestamp":1539043200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00106-018-0573-7","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T13:51:05Z","timestamp":1539093065000},"page":"857-873","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapie des kutanen malignen Melanoms im Kopf-Hals-Bereich"],"prefix":"10.1007","volume":"66","author":[{"given":"B.","family":"Frerich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,9]]},"reference":[{"key":"573_CR1","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/CMR.0b013e3283577b96","volume":"22","author":"V Giorgi de","year":"2012","unstructured":"de Giorgi V, Rossari S, Gori A, Grazzini M, Savarese I, Crocetti E, Cervadoro E, Massi D (2012) The prognostic impact of the anatomical sites in the \u201ehead and neck melanoma\u201c: scalp versus face and neck. Melanoma Res 22:402\u2013405","journal-title":"Melanoma Res"},{"key":"573_CR2","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1245\/s10434-013-2977-7","volume":"20","author":"N Fadaki","year":"2013","unstructured":"Fadaki N, Li R, Parrett B, Sanders G, Thummala S, Martineau L, Cardona-Huerta S, Miranda S, Cheng ST, Miller JR 3rd, Singer M, Cleaver JE, Kashani-Sabet M, Leong SP (2013) Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome? Ann Surg Oncol 20:3089\u20133097","journal-title":"Ann Surg Oncol"},{"key":"573_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/CMR.0000000000000042","volume":"24","author":"P Ghazal Al","year":"2014","unstructured":"Al Ghazal P, Gutzmer R, Satzger I, Starz H, Bader C, Thoms KM, Mitteldorf C, Schon MP, Kapp A, Bertsch HP, Kretschmer L (2014) Lower prevalence of lymphatic metastasis and poorer survival of the sentinel node-negative patients limit the prognostic value of sentinel node biopsy for head or neck melanomas. Melanoma Res 24:158\u2013164","journal-title":"Melanoma Res"},{"key":"573_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature08658","volume":"463","author":"ED Pleasance","year":"2010","unstructured":"Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordonez GR, Bignell GR, Ye K, Alipaz J, Bauer MJ, Beare D, Butler A, Carter RJ, Chen L, Cox AJ, Edkins S, Kokko-Gonzales PI, Gormley NA, Grocock RJ, Haudenschild CD, Hims MM, James T, Jia M, Kingsbury Z, Leroy C, Marshall J, Menzies A, Mudie LJ, Ning Z, Royce T, Schulz-Trieglaff OB, Spiridou A, Stebbings LA, Szajkowski L, Teague J, Williamson D, Chin L, Ross MT, Campbell PJ, Bentley DR, Futreal PA, Stratton MR (2010) A comprehensive catalogue of somatic mutations from a\u00a0human cancer genome. Nature 463:191\u2013196","journal-title":"Nature"},{"key":"573_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1289\/ehp.93101252","volume":"101","author":"PJ Nelemans","year":"1993","unstructured":"Nelemans PJ, Groenendal H, Kiemeney LA, Rampen FH, Ruiter DJ, Verbeek AL (1993) Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals. Environ Health Perspect 101:252\u2013255","journal-title":"Environ Health Perspect"},{"key":"573_CR6","volume-title":"S3-Leitlinie Pr\u00e4vention von Hautkrebs. Version 1.1, AWMF Registernummer: 032\/052OL","author":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF)","year":"2016","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2016) S3-Leitlinie Pr\u00e4vention von Hautkrebs. Version 1.1, AWMF Registernummer: 032\/052OL. \n                    http:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/hautkrebs-praevention\/\n                    \n                  . Zugegriffen: 5. Jan. 2018"},{"key":"573_CR7","volume-title":"Krebs in Deutschland f\u00fcr 2013\/2014, 11. Ausgabe, Berlin","year":"2017","unstructured":"Robert Koch-Institut (Hrsg) (2017) Krebs in Deutschland f\u00fcr 2013\/2014, 11. Ausgabe, Berlin. \n                    www.krebsdaten.de\n                    \n                  . Zugegriffen: 27. Dez. 2017"},{"key":"573_CR8","unstructured":"Gemeinsames Krebsregister (Hrsg) (2015) Krebsinzidenz und Krebsmortalit\u00e4t 2009\u20132012 (Jahresbericht) Berlin."},{"key":"573_CR9","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr., Morton DL, Ross MI, Sober AJ, Sondak VK (2009) Final version of 2009 AJCC melanoma staging and classification. J\u00a0Clin Oncol 27:6199\u20136206","journal-title":"J Clin Oncol"},{"key":"573_CR10","volume-title":"S3-Leitlinie zur Diagnostik, Therapie und Nachsorge des Melanoms. Langversion 2.0, AWMF Registernummer: 032\/024OL","author":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF)","year":"2016","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2016) S3-Leitlinie zur Diagnostik, Therapie und Nachsorge des Melanoms. Langversion 2.0, AWMF Registernummer: 032\/024OL. \n                    http:\/\/leitlinienprogramm-onkologie.de\/Melanom.65.0.html\n                    \n                  . Zugegriffen: 27. Dez. 2017"},{"key":"573_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI et al (2017) Melanoma staging: Evidence\u2010based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67:472\u2013492","journal-title":"CA Cancer J Clin"},{"key":"573_CR12","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/cncr.11196","volume":"97","author":"MF Azzola","year":"2003","unstructured":"Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y (2003) Tumor mitotic rate is a\u00a0more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a\u00a0single center. Cancer 97:1488\u20131498","journal-title":"Cancer"},{"key":"573_CR13","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1245\/s10434-012-2701-z","volume":"20","author":"ME Egger","year":"2013","unstructured":"Egger ME, Callender GG, McMasters KM, Ross MI, Martin RC 2nd, Edwards MJ, Urist MM, Noyes RD, Sussman JJ, Reintgen DS, Stromberg AJ, Scoggins CR (2013) Diversity of stage III melanoma in the era of sentinel lymph node biopsy. Ann Surg Oncol 20:956\u2013963","journal-title":"Ann Surg Oncol"},{"key":"573_CR14","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1200\/JCO.2009.27.1627","volume":"28","author":"CM Balch","year":"2010","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Ding S, Byrd DR, Cascinelli N, Cochran AJ, Coit DG, Eggermont AM, Johnson T, Kirkwood JM, Leong SP, McMasters KM, Mihm MC Jr., Morton DL, Ross MI, Sondak VK (2010) Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J\u00a0Clin Oncol 28:2452\u20132459","journal-title":"J Clin Oncol"},{"key":"573_CR15","first-page":"669","volume":"159","author":"ME Vestergaard","year":"2008","unstructured":"Vestergaard ME, Macaskill P, Holt PE, Menzies SW (2008) Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a\u00a0meta-analysis of studies performed in a\u00a0clinical setting. Br J Dermatol 159:669\u2013676","journal-title":"Br J Dermatol"},{"key":"573_CR16","volume-title":"Clinical practice guidelines in oncology \u2013 melanoma version I.2018. National comprehensive cancer network","author":"NCCN","year":"2017","unstructured":"NCCN (2017) Clinical practice guidelines in oncology \u2013 melanoma version I.2018. National comprehensive cancer network. http:\/NCCN.org. Zugegriffen: 27. Dez. 2017"},{"key":"573_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.amjsurg.2013.01.023","volume":"205","author":"JK Mills","year":"2013","unstructured":"Mills JK, White I, Diggs B, Fortino J, Vetto JT (2013) Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma. Am J Surg 205:585\u2013590 (discussion 590)","journal-title":"Am J Surg"},{"key":"573_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.clindermatol.2009.06.013","volume":"28","author":"A Pflugfelder","year":"2010","unstructured":"Pflugfelder A, Weide B, Eigentler TK, Forschner A, Leiter U, Held L, Meier F, Garbe C (2010) Incisional biopsy and melanoma prognosis: facts and controversies. Clin Dermatol 28:316\u2013318","journal-title":"Clin Dermatol"},{"key":"573_CR19","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1245\/s10434-006-9302-7","volume":"14","author":"BG Molenkamp","year":"2007","unstructured":"Molenkamp BG, Sluijter BJ, Oosterhof B, Meijer S, van Leeuwen PA (2007) Non-radical diagnostic biopsies do not negatively influence melanoma patient survival. Ann Surg Oncol 14:1424\u20131430","journal-title":"Ann Surg Oncol"},{"key":"573_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004835.pub2","author":"MJ Sladden","year":"2009","unstructured":"Sladden MJ, Balch C, Barzilai DA, Berg D, Freiman A, Handiside T, Hollis S, Lens MB, Thompson JF (2009) Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD004835.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"573_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/SLA.0b013e318207a331","volume":"253","author":"S Mocellin","year":"2011","unstructured":"Mocellin S, Pasquali S, Nitti D (2011) The impact of surgery on survival of patients with cutaneous melanoma: revisiting the role of primary tumor excision margins. Ann Surg 253:238\u2013243","journal-title":"Ann Surg"},{"key":"573_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ctrv.2015.10.013","volume":"42","author":"K Wheatley","year":"2016","unstructured":"Wheatley K, Wilson JS, Gaunt P, Marsden JR (2016) Surgical excision margins in primary cutaneous melanoma: a meta-analysis and Bayesian probability evaluation. Cancer Treat Rev 42:73\u201381","journal-title":"Cancer Treat Rev"},{"key":"573_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJMoa030681","volume":"350","author":"JM Thomas","year":"2004","unstructured":"Thomas JM, Newton-Bishop J, A\u2019Hern R, Coombes G, Timmons M, Evans J, Cook M, Theaker J, Fallowfield M, O\u2019Neill T, Ruka W, Bliss JM, United Kingdom Melanoma Study G, British Association of Plastic S, Scottish Cancer Therapy N (2004) Excision margins in high-risk malignant melanoma. N\u00a0Engl J Med 350:757\u2013766","journal-title":"N Engl J Med"},{"key":"573_CR24","first-page":"101","volume":"8","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Smith T, Ross MI, Urist MM, Karakousis CP, Temple WJ, Mihm MC, Barnhill RL, Jewell WR, Wanebo HJ, Desmond R, Investigators from the Intergroup Melanoma Surgical T (2001) Long-term results of a\u00a0prospective surgical trial comparing 2\u202fcm vs. 4\u202fcm excision margins for 740 patients with 1\u20134\u202fmm melanomas. Ann Surg Oncol 8:101\u2013108","journal-title":"Ann Surg Oncol"},{"key":"573_CR25","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/ddg.13342","volume":"15","author":"R Gutzmer","year":"2017","unstructured":"Gutzmer R, Frerich B, Krause-Bergmann A, Dippel E (2017) Ist eine komplette Lymphknotendissektion beim malignen Melanom mit positivem Sentinel notwendig? J Dtsch Dermatol Ges 15:1175\u20131176","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"573_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/CMR.0b013e32833ba9ff","volume":"20","author":"C Kunte","year":"2010","unstructured":"Kunte C, Geimer T, Baumert J, Konz B, Volkenandt M, Flaig M, Ruzicka T, Berking C, Schmid-Wendtner MH (2010) Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma. Melanoma Res 20:330\u2013337","journal-title":"Melanoma Res"},{"key":"573_CR27","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/cncr.26288","volume":"118","author":"AB Erman","year":"2012","unstructured":"Erman AB, Collar RM, Griffith KA, Lowe L, Sabel MS, Bichakjian CK, Wong SL, McLean SA, Rees RS, Johnson TM, Bradford CR (2012) Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Cancer 118:1040\u20131047","journal-title":"Cancer"},{"key":"573_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1177\/0194599812444268","volume":"147","author":"BM Parrett","year":"2012","unstructured":"Parrett BM, Kashani-Sabet M, Singer MI, Li R, Thummala S, Fadaki N, Leong SP (2012) Long-term prognosis and significance of the sentinel lymph node in head and neck melanoma. Otolaryngol Head Neck Surg 147:699\u2013706","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"573_CR29","unstructured":"Erhebungsbogen f\u00fcr Hautkrebszentren der Deutschen Krebsgesellschaft (VersH1; 09102017j) \n                    http:\/\/www.onkozert.de\/hauttumorzentren.htm\n                    \n                  . Zugegriffen: 17. Jan. 2018"},{"key":"573_CR30","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","volume":"17","author":"U Leiter","year":"2016","unstructured":"Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer N, Berking C, Sunderkotter C, Kaatz M, Schulte KW, Lehmann P, Vogt T, Ulrich J, Herbst R, Gehring W, Simon JC, Keim U, Martus P, Garbe C, German Dermatologic Cooperative Oncology G (2016) Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a\u00a0multicentre, randomised, phase 3 trial. Lancet Oncol 17:757\u2013767","journal-title":"Lancet Oncol"},{"key":"573_CR31","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters M, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM (2017) Completion dissection or observation for sentinel-node metastasis in melanoma. N\u00a0Engl J Med 376:2211\u20132222","journal-title":"N Engl J Med"},{"key":"573_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/0194599815605494","volume":"154","author":"VA Fritsch","year":"2016","unstructured":"Fritsch VA, Cunningham JE, Lentsch EJ (2016) Completion lymph node dissection based on risk of Nonsentinel metastasis in cutaneous melanoma of the head and neck. Otolaryngol Head Neck Surg 154:94\u2013103","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"573_CR33","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/0194599811432672","volume":"146","author":"VA Smith","year":"2012","unstructured":"Smith VA, Cunningham JE, Lentsch EJ (2012) Completion node dissection in patients with sentinel node-positive melanoma of the head and neck. Otolaryngol Head Neck Surg 146:591\u2013599","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"573_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejca.2017.09.014","volume":"86","author":"AMM Eggermont","year":"2017","unstructured":"Eggermont AMM, Dummer R (2017) The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients. Eur J Cancer 86:101\u2013105","journal-title":"Eur J Cancer"},{"key":"573_CR35","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1245\/s10434-012-2401-8","volume":"19","author":"KP Wevers","year":"2012","unstructured":"Wevers KP, Bastiaannet E, Poos HP, van Ginkel RJ, Plukker JT, Hoekstra HJ (2012) Therapeutic lymph node dissection in melanoma: different prognosis for different macrometastasis sites? Ann Surg Oncol 19:3913\u20133918","journal-title":"Ann Surg Oncol"},{"key":"573_CR36","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/BF02071524","volume":"16","author":"CJ O\u2019Brien","year":"1992","unstructured":"O\u2019Brien CJ, Gianoutsos MP, Morgan MJ (1992) Neck dissection for cutaneous malignant melanoma. World J Surg 16:222\u2013226","journal-title":"World J Surg"},{"key":"573_CR37","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1080\/0036554021000028067","volume":"122","author":"JE Medina","year":"2002","unstructured":"Medina JE, Ferlito A, Brandwein MS, Fisher SR, Pellitteri PK, Shaha AR, Pitman KT, Robbins KT, Rinaldo A, Silver CE, Byers RM, O\u2019Brien CJ (2002) Current management of cutaneous malignant melanoma of the head and neck. Acta Otolaryngol 122:900\u2013906","journal-title":"Acta Otolaryngol"},{"key":"573_CR38","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0030-6665(05)70091-8","volume":"31","author":"RM Byers","year":"1998","unstructured":"Byers RM (1998) Treatment of the neck in melanoma. Otolaryngol Clin North Am 31:833\u2013839","journal-title":"Otolaryngol Clin North Am"},{"key":"573_CR39","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1067\/j.cpsurg.2006.08.003","volume":"43","author":"CE Schmalbach","year":"2006","unstructured":"Schmalbach CE, Johnson TM, Bradford CR (2006) The management of head and neck melanoma. Curr Probl Surg 43:781\u2013835","journal-title":"Curr Probl Surg"},{"key":"573_CR40","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/hed.21089","volume":"31","author":"HM Reynolds","year":"2009","unstructured":"Reynolds HM, Smith NP, Uren RF, Thompson JF, Dunbar PR (2009) Three-dimensional visualization of skin lymphatic drainage patterns of the head and neck. Head Neck 31:1316\u20131325","journal-title":"Head Neck"},{"key":"573_CR41","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.bjps.2014.04.017","volume":"67","author":"M Wiener","year":"2014","unstructured":"Wiener M, Uren RF, Thompson JF (2014) Lymphatic drainage patterns from primary cutaneous tumours of the forehead: refining the recommendations for selective neck dissection. J\u00a0Plast Reconstr Aesthet Surg 67:1038\u20131044","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"573_CR42","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1001\/jamaoto.2014.2056","volume":"140","author":"M Geltzeiler","year":"2014","unstructured":"Geltzeiler M, Monroe M, Givi B, Vetto J, Andersen P, Gross N (2014) Regional control of head and neck melanoma with selective neck dissection. JAMA Otolaryngol Head Neck Surg 140:1014\u20131018","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"573_CR43","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.amjoto.2014.06.011","volume":"35","author":"M Supriya","year":"2014","unstructured":"Supriya M, Narasimhan V, Henderson MA, Sizeland A (2014) Managing regional metastasis in patients with cutaneous head and neck melanoma\u2014is selective neck dissection appropriate? Am J Otolaryngol 35:610\u2013616","journal-title":"Am J Otolaryngol"},{"key":"573_CR44","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","volume":"375","author":"AM Eggermont","year":"2016","unstructured":"Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, Lebbe C, Ferraresi V, Smylie M, Weber JS, Maio M, Bastholt L, Mortier L, Thomas L, Tahir S, Hauschild A, Hassel JC, Hodi FS, Taitt C, de Pril V, de Schaetzen G, Suciu S, Testori A (2016) Prolonged survival in stage III melanoma with Ipilimumab adjuvant therapy. N\u00a0Engl J Med 375:1845\u20131855","journal-title":"N Engl J Med"},{"key":"573_CR45","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1470-2045(12)70138-9","volume":"13","author":"BH Burmeister","year":"2012","unstructured":"Burmeister BH, Henderson MA, Ainslie J, Fisher R, Di Iulio J, Smithers BM, Hong A, Shannon K, Scolyer RA, Carruthers S, Coventry BJ, Babington S, Duprat J, Hoekstra HJ, Thompson JF (2012) Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a\u00a0randomised trial. Lancet Oncol 13:589\u2013597","journal-title":"Lancet Oncol"},{"key":"573_CR46","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1200\/JCO.2014.56.6018","volume":"33","author":"M Maio","year":"2015","unstructured":"Maio M, Grob JJ, Aamdal S, Bondarenko I, Robert C, Thomas L, Garbe C, Chiarion-Sileni V, Testori A, Chen TT, Tschaika M, Wolchok JD (2015) Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a\u00a0phase III trial. J\u00a0Clin Oncol 33:1191\u20131196","journal-title":"J Clin Oncol"},{"key":"573_CR47","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","volume":"33","author":"D Schadendorf","year":"2015","unstructured":"Schadendorf D, Hodi FS, Robert C, Weber JS, Margolin K, Hamid O, Patt D, Chen TT, Berman DM, Wolchok JD (2015) Pooled analysis of long-term survival data from phase II and phase III trials of Ipilimumab in unresectable or metastatic melanoma. J\u00a0Clin Oncol 33:1889\u20131894","journal-title":"J Clin Oncol"},{"key":"573_CR48","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","volume":"377","author":"JD Wolchok","year":"2017","unstructured":"Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob JJ, Cowey CL, Lao CD, Wagstaff J, Schadendorf D, Ferrucci PF, Smylie M, Dummer R, Hill A, Hogg D, Haanen J, Carlino MS, Bechter O, Maio M, Marquez-Rodas I, Guidoboni M, McArthur G, Lebbe C, Ascierto PA, Long GV, Cebon J, Sosman J, Postow MA, Callahan MK, Walker D, Rollin L, Bhore R, Hodi FS, Larkin J (2017) Overall survival with combined nivolumab and Ipilimumab in advanced melanoma. N\u00a0Engl J Med 377:1345\u20131356","journal-title":"N Engl J Med"},{"key":"573_CR49","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jaad.2011.06.019","volume":"66","author":"JH Kunishige","year":"2012","unstructured":"Kunishige JH, Brodland DG, Zitelli JA (2012) Surgical margins for melanoma in situ. J\u00a0Am Acad Dermatol 66:438\u2013444","journal-title":"J Am Acad Dermatol"},{"key":"573_CR50","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1524-4725.2010.01618.x","volume":"36","author":"JR DeBloom 2nd","year":"2010","unstructured":"DeBloom JR 2nd, Zitelli JA, Brodland DG (2010) The invasive growth potential of residual melanoma and melanoma in situ. Dermatol Surg 36:1251\u20131257","journal-title":"Dermatol. Surg."},{"key":"573_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12285-017-0134-1","volume":"11","author":"B Frerich","year":"2018","unstructured":"Frerich B, Prall F (2018) Basalzellkarzinom der Gesichts- und Kopfhaut \u2013 Update der Therapieverfahren. Mkg-Chir 11:49\u201363","journal-title":"Mkg-Chir"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00106-018-0573-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-018-0573-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-018-0573-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T23:19:36Z","timestamp":1570576776000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00106-018-0573-7"}},"subtitle":["Ein Update"],"short-title":[],"issued":{"date-parts":[[2018,10,9]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["573"],"URL":"https:\/\/doi.org\/10.1007\/s00106-018-0573-7","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,9]]},"assertion":[{"value":"9 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0Frerich gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine vom Autor durchgef\u00fchrten Studien an Menschen oder Tieren. Alle Patienten, die \u00fcber Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}